Pretreatment HIV Drug Resistance Among Adults Initiating or Re-Initiating First-Line Antiretroviral Therapy in Zimbabwe: Fast-Tracking the Transition to Dolutegravir-Based First-Line Regimens?-Reference-Cited by-同舟云学术

Pretreatment HIV Drug Resistance Among Adults Initiating or Re-Initiating First-Line Antiretroviral Therapy in Zimbabwe: Fast-Tracking the Transition to Dolutegravir-Based First-Line Regimens?

Published:2021-10-01 Issue:10 Volume:37 Page:776-783
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Kouamou Vinie¹,Mavetera Justice¹,Manasa Justen²,Ndhlovu Chiratidzo Ellen¹,Katzenstein David³,McGregor Alan Michael¹

Affiliation:

1. Department of Medicine, College of Health Sciences, University of Zimbabwe, Harare, Zimbabwe.

2. Department of Medical Microbiology, College of Health Sciences, University of Zimbabwe, Harare, Zimbabwe.

3. Department of Molecular Biology, Biomedical Research and Training Institute, Harare, Zimbabwe.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

https://www.liebertpub.com/doi/pdf/10.1089/aid.2020.0242

Reference42 articles.

1. 1. Joint United Nations Programme on 90-90-90: An ambitious treatment target to help end the AIDS epidemic. Joint United Nations Programme on HIV/AIDS, Geneva, 2014, p. 33.

2. 2. World Health Organization: Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV: Interim guidelines: Supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. World Health Organization, Geneva, 2018.

3. Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study

4. Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe

5. Pretreatment HIV drug resistance results in virological failure and accumulation of additional resistance mutations in Ugandan children

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of pretreatment HIV resistance to integrase inhibitors in West African and Southeast Asian countries;Journal of Antimicrobial Chemotherapy;2024-03-28

2. Virologic outcomes on dolutegravir-, atazanavir-, or efavirenz-based ART in urban Zimbabwe: A longitudinal study;PLOS ONE;2024-02-23

3. Strengthening and enhancing national antiretroviral drug resistance surveillance in Zimbabwe—A country that has reached UNAIDS 95-95-95 amongst adults;Frontiers in Public Health;2024-02-14

4. Virological, weight, and drug resistance outcomes among patients initiating a dolutegravir-based first-line antiretroviral therapy regimen in Zimbabwe;AIDS;2024-01-16

5. Virologic outcomes on dolutegravir-, atazanavir-, or efavirenz-based ART in urban Zimbabwe: A longitudinal study;2023-10-15